Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04036799Active Not Recruiting

PRecIsion Medicine in CardiomyopathY

Role: collaborator

NCT01182350Phase 2Terminated

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

Role: collaborator

NCT02403466Not ApplicableCompleted

IIPE-PRIS Accelerating Safe Signouts

Role: collaborator

NCT01753063Not ApplicableCompleted

Managing Patient Expectations in Pediatric Weight Management

Role: collaborator

All 4 trials loaded